Deal slippage diagnosis is the systematic analysis of why deals that should close this quarter keep pushing to next quarter—costing you 20-40% of your forecasted revenue. It’s the process of identifying the root causes behind deals that perpetually move from “closing this month” to “probably next month” in your pipeline. Picture this: It’s Friday afternoon.
Picture a B2B SaaS founder staring at their competitor’s new feature announcement. Again. The same features they just shipped last quarter, now copied and marketed better. The zag book refers to Marty Neumeier’s radical differentiation framework where successful brands achieve market dominance by doing the opposite of their competitors—when everyone else zigs, you zag. This
Venture studios make money for LPs through a fundamentally different model than traditional VCs — they build and de-risk companies from inception, typically capturing 20-50% equity stakes while reducing failure rates from 90% to 60-70%. This operational approach generates returns of 3-5x compared to the VC industry average of 2.5x, primarily because studios control more
NIL deal entrepreneurship is the emerging business model where college athletes monetize their name, image, and likeness through partnerships, sponsorships, and equity deals—transforming 460,000+ NCAA athletes into instant entrepreneurs overnight. But here’s what nobody tells you: 73% of these athlete ventures fail within their first year, not because they lack talent or audience, but because